Vaxxinity, Inc. (VAXX)

Vaxxinity Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.93	33.48	144.89	31.14	0.48
Short-Term Investments	25.71	53.58	0.87	0.01	-
Cash & Short-Term Investments	30.64	87.06	145.75	31.15	0.48
Cash Growth	-64.81%	-40.27%	367.87%	6444.75%	-
Accounts Receivable	-	-	-	0.03	-
Other Receivables	0.41	0.41	0.69	0.36	0.3
Receivables	0.41	0.41	0.69	0.39	0.3
Inventory	-	0.25	3.52	3.3	-
Prepaid Expenses	1.24	4.55	4.12	-	-
Restricted Cash	0.11	1.1	0.17	-	-
Other Current Assets	0.84	0.52	0.04	0.83	0.66
Total Current Assets	33.23	93.89	154.3	35.67	1.44
Property, Plant & Equipment	11.08	12.51	12.37	12.16	0.16
Long-Term Deferred Charges	-	-	-	2.25	-
Other Long-Term Assets	-	-	-	0.06	-
Total Assets	44.31	106.4	166.67	50.14	1.6

Liabilities

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	1.78	5.3	3.19	1.02	1.28
Accrued Expenses	3.34	11.37	4.52	2.74	5.41
Short-Term Debt	-	-	-	16.62	2.73
Current Portion of Long-Term Debt	1.91	1.5	0.38	10.98	10.46
Other Current Liabilities	10.58	12.77	19.41	8	-
Total Current Liabilities	17.61	30.94	27.49	39.36	19.88
Long-Term Debt	13.26	13.05	10.32	10.7	1.12
Long-Term Leases	-	-	-	-	0.03
Other Long-Term Liabilities	0.04	0.24	0.24	24.98	2.26
Total Liabilities	30.9	44.22	38.05	75.04	23.29

Shareholders' Equity

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.28	0.28	0.28	0.27	0.27
Additional Paid-In Capital	374.76	366.8	357.82	4.68	3.59
Retained Earnings	-361.64	-304.7	-229.48	-92.31	-52.35
Treasury Stock	-	-	-	-0.02	-0.02
Comprehensive Income & Other	0.01	-0.2	-	-	-
Total Common Equity	13.41	62.18	128.62	-87.38	-48.51
Shareholders' Equity	13.41	62.18	128.62	-24.9	-21.69
Total Liabilities & Equity	44.31	106.4	166.67	50.14	1.6

Additional Metrics

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	15.17	14.55	10.7	38.29	14.33
Net Cash (Debt)	15.47	72.51	135.06	-7.14	-13.86
Net Cash Growth	-78.67%	-46.31%	-	-	-
Net Cash Per Share	0.12	0.58	1.76	-0.11	-0.41
Filing Date Shares Outstanding	126.75	126.06	125.84	68.19	34.21
Total Common Shares Outstanding	126.75	126.06	125.39	68.19	34.21
Working Capital	15.63	62.95	126.81	-3.68	-18.44
Book Value Per Share	0.11	0.49	1.03	-1.28	-1.42
Tangible Book Value	13.41	62.18	128.62	-87.38	-48.51
Tangible Book Value Per Share	0.11	0.49	1.03	-1.28	-1.42
Machinery	15.72	15.22	13.9	12.95	0.32
Construction In Progress	0.13	0.07	0.2	-	-
Leasehold Improvements	0.58	0.4	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error